Advertisement

Table of Contents

May 11, 2017; 129 (19)

INSIDE BLOOD COMMENTARIES

REVIEW ARTICLE

CLINICAL TRIALS AND OBSERVATIONS

GENE THERAPY

IMMUNOBIOLOGY

LYMPHOID NEOPLASIA

  • Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice
    Idoia García-Ramírez, Saber Tadros, Inés González-Herrero, Alberto Martín-Lorenzo, Guillermo Rodríguez-Hernández, Dalia Moore, Lucía Ruiz-Roca, Oscar Blanco, Diego Alonso-López, Javier De Las Rivas, Keenan Hartert, Romain Duval, David Klinkebiel, Martin Bast, Julie Vose, Matthew Lunning, Kai Fu, Timothy Greiner, Fernando Rodrigues-Lima, Rafael Jiménez, Francisco Javier García Criado, María Begoña García Cenador, Paul Brindle, Carolina Vicente-Dueñas, Ash Alizadeh, Isidro Sánchez-García and Michael R. Green

MYELOID NEOPLASIA

THROMBOSIS AND HEMOSTASIS

TRANSPLANTATION

LETTERS TO BLOOD

  • Venetoclax and obinutuzumab in chronic lymphocytic leukemia
    Kirsten Fischer, Othman Al-Sawaf, Anna-Maria Fink, Mark Dixon, Jasmin Bahlo, Simon Warburton, Thomas J. Kipps, Robert Weinkove, Sue Robinson, Till Seiler, Stephen Opat, Carolyn Owen, Javier López, Kathryn Humphrey, Rod Humerickhouse, Eugen Tausch, Lukas Frenzel, Barbara Eichhorst, Clemens-M. Wendtner, Stephan Stilgenbauer, Anton W. Langerak, Jacque J. M. van Dongen, Sebastian Böttcher, Matthias Ritgen, Valentin Goede, Mehrdad Mobasher and Michael Hallek
  • FNDC3B is another novel partner fused to RARA in the t(3;17)(q26;q21) variant of acute promyelocytic leukemia
    Chi Keung Cheng, Angela Z. Wang, Terry H. Y. Wong, Thomas S. K. Wan, Joyce S. Cheung, Radha Raghupathy, Natalie P. H. Chan and Margaret H. L. Ng

BLOOD WORK